Although they havent been officially approved for other treatments, the semaglutides in Ozempic and Wegovy have shown a variety of other health benefits
Schedule a Consultation Schedule a FREE consult with our medical provider to determine if you are a candidate
It is not yet approved for general use, but early research has made it one of the most talked about developments in metabolic health
As the first dual GIP and GLP-1 receptor agonist, often called a twincretin, it offers simultaneous control of blood sugar and body weight, outpacing traditional single-agonist therapies
Cardiac symptoms are frequently exertional, worsening with physical activity and improving with rest, though unstable angina or acute coronary syndrome can occur at rest
Were getting over 15% weight loss in patients with type 2 diabetes